Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease

BACKGROUND: Use of enzyme replacement therapy (ERT) to treat Fabry disease, caused by deficient lysosomal α-galactosidase A activity, can lead to formation of neutralizing antidrug antibodies (ADAs). These antibodies are associated with increased accumulation of plasma globotriaosylceramide (Gb3) an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Lenders, Malte, Neußer, Leon Paul, Rudnicki, Michael, Nordbeck, Peter, Canaan-Kühl, Sima, Nowak, Albina, Cybulla, Markus, Schmitz, Boris, Lukas, Jan, Wanner, Christoph, Brand, Stefan-Martin, Brand, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2018
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6287863/
https://ncbi.nlm.nih.gov/pubmed/30385651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018070740
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados